Home

MICHAEL R MINOGUE

CIK 1286370 · CHAIRMAN, PRESIDENT, CEO · last filed 2026-05-21

MICHAEL R MINOGUE is a CHAIRMAN, PRESIDENT, CEO who has filed 132 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for PODD, was dated May 21, 2026. Across all open-market trades the lifetime net is −$162.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.8M across reported positions. 125 SEC filings were submitted jointly with ABIOMED INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.80M

Companies

5

Total Filings

132

Lifetime Open-Market Net

-$162.81M

Filer Profile

Reported Address
C/O INSULET CORPORATION
100 NAGOG PARK
ACTON, MA 01720
Related Filers
ABIOMED INC — 125 joint filings, latest 2022-12-27
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PODD Director 19,921 $140.67 $2.80M $1.51M 16 2026-05-21
ABIOMED INC (ABMD) Delisted CHAIRMAN, PRESIDENT, CEO 380,048 $381.02 $144.81M -$105.99M 37 2022-12-20
ABIOMED INC (APOL) Delisted President, CEO, Chairman 306,760 — — -$57.60M 74 2016-10-04
WORLD HEART CORP (WHRT) Delisted Director 2,731,666 — — -$317.2K 1 2009-05-11
LIFECELL CORP (VITA) Delisted Director 0 — — -$400.0K 3 2008-06-04

Recent Filings

132 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-21 PODD Grant (A) +1,660 $0 EDGAR
2026-02-26 PODD Buy (P) +2,030 $499.8K EDGAR
2025-08-21 PODD Gift (G) — $0 EDGAR
2025-05-27 PODD Grant (A) +778 $0 EDGAR
2024-06-05 PODD Gift (G) — $0 EDGAR
2024-05-23 PODD Grant (A) +1,380 $0 EDGAR
2023-08-18 PODD Gift (G) — $0 EDGAR
2023-05-24 PODD Mixed +4,143 $1.01M EDGAR
2022-12-27 — Mixed −410,632 $0
2022-12-20 ABIOMED INC (ABMD) Delisted Grant (A) +1 $0 EDGAR
Showing 1–10 of 132
Page 1 of 14
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.